Consolidated Statement of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	No Par, Preferred Stock No Par, Series A Preferred Stock	No Par, Common Stock	Retained Earnings (Accumulated deficit)	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2023	$ 2,889	$ 6,000	$ 98,100	$ (86,683)	$ (14,528)
Balance at beginning of period (in shares) at Dec. 31, 2023		1,000	12,222,881
Net income (loss)	24,347			24,347
Stock-based compensation expense	78		$ 78
Dividends on Series A preferred stock	(420)			(420)
Redemption premium on Series A Preferred Stock	(397)			(397)
Redemption of Series A preferred stock	(6,000)	$ (6,000)
Redemption of Series A preferred stock, shares		(1,000)
Other comprehensive income (loss)	1,028				1,028
Balance at end of period at Dec. 31, 2024	21,525		$ 98,178	(63,153)	(13,500)
Balance at end of period (in shares) at Dec. 31, 2024			12,222,881
Net income (loss)	(18,438)			(18,438)
Issuance of warrants	1,924		$ 1,924
Stock-based compensation expense	56		56
Other comprehensive income (loss)	3,899				3,899
Balance at end of period at Dec. 31, 2025	$ 8,966		$ 100,158	$ (81,591)	$ (9,601)
Balance at end of period (in shares) at Dec. 31, 2025			12,222,881